Free Shipping on orders over $50

PRODUCT SUMMARY

Essential Fatty Acids - Concentrated Omega-3 1,200 mg Fish Oil Natural Orange Flavor Softgels (120 Count)

Availability: In stock
Stock Number :EFA-107-SG-120
  • General Health and Wellness
  • Heart Health – Cardiovascular Support
  • Hair – Skin – Nails
  • Beauty Health
  • Eye Health and Visual Support
  • Immune Support
  • Nervous System Support
  • Pain and Inflammation
  • Prostate Health
  • Quick Notes:

    • Sourced from fresh cold water sources!
    • 1200 mg highly concentrated fish oil softgel
    • Each softgel contains a minimum of 360 mg

    View More Information
    pdfProduct Sheet PDF(429.97 KB )Download
    pdfFAQ PDF                   (703.78 KB )Download

    List Price: $48.01

    Price: $28.76

    Quantity:

    Product Information

    Quick Notes:

    • Sourced from fresh cold water sources!
    • 1200 mg highly concentrated fish oil softgel!
    • Each softgel contains a minimum of 360 mg EPA and 240 mg DHA!
    • Includes all natural orange oil for an aesthetically pleasing scent!
    • 1 softgel provides nearly twice as much EPA/DHA as standard fish oil products!
    • Supports healthy heart and brain function!
    • Promotes cellular health and maintain normal triglyceride levels!
    • May reduce the risk of coronary heart disease!
    • Molecular distillation removes heavy metals such as mercury, PCBs, and dioxins from fish oil!
    • Thoroughly tested for pesticides, heavy metals, dioxins, and PCBs!
       

    Overview:

    Omega-3:

    Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are two nutritionally important omega-3 fatty acids. Both EPA and DHA are essential for efficient functioning of the brain and body at a cellular level. Deficiency of DHA in body has been linked to depression, schizophrenia, memory loss and a higher risk of developing Alzheimer’s disease. Inadequate intake of omega-3 fatty acids during pregnancy may result in an increased incidence of prematurity, low birth weight, and hyperactivity in children. Essential fatty acids (EFAs) have a part in running virtually every vital system in the human body. In order for these systems to function properly, omega-3 and omega-6 fatty acids should be consumed in an equal ratio. For centuries the human diet consisted of an equal ratio of EFAs, but modern food processing techniques and dietary tendencies have most Americans consuming omega-6s at high omega 6 to 3 ratio. This creates an imbalance in omega-3 fatty acids. This highly concentrated omega-3 fatty acid softgel contains twice as much eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as many omega-3 products, and in a convenient one per day softgel.
     

    Research indicates:

    • Instrumental in regulating inflammation, blood pressure and thickness, hormone production, and the activities of the immune and central nervous systems
    • Important for infants (and a developing fetus) for proper development of the brain and retina of the eyes
    • Studies suggest that Attention Deficit Hyperactivity Disorder (ADHD) may be linked to omega-3 deficiency
    • Deficiencies of omega-3 may also be linked to depression
    • May be helpful for symptoms of Crohn’s disease
    • Researchers hypothesize omega-3 may help prevent breast, prostate and colon cancers
    • Supports cardiovascular health by lowering blood pressure, relaxing blood vessels, and lowering cholesterol levels
    • Has been shown to decrease elevated serum triglycerides
    • May also reduce pain for sufferers of rheumatoid arthritis
    • Deficiencies have also been found in people who have allergies, asthma, and skin disorders like eczema and psoriasis



       

    Heavy Metal Analysis Overview

     

    MERCURYA

     

    CADMIUMB

     

    LEADB

     

    Acceptance Criteria

     

    6.8 mcg per day consumed safely

     

    NMT

    4.1 mcg/day

     

    NMT 0.5 mcg/

    day

     

    PRODUCT

    Per serving

    Per serving

    Per serving

    Concentrated Omega-3

     

    ND

     

    ND

     

    ND

     

    Kids DHA

     

    <0.016 mcg/ day

     

    ND

     

    <0.041 mcg/day

     

    Ultimate Omega Complex

     

    <0.20 mcg/ day

     

    <0.99 mcg/ day

     

    ND

    Materials and Processing:

    The fish species used in EverLife fish oil products are clearly listed on the product label. The oils are derived from short life span fish that are low on the food chain, including anchovy, mackerel, and/ or cod. These species do not have increased amounts of contaminants that may be found in fish with longer life spans and that are higher on the food chain such as shark, swordfish, tile fish, and king mackerel.

    Testing & Specifications:

    EverLife Labs uses quality fish oil that has appropriate testing performs performed. Furthermore, our materials comply with the monographs set by C.R.N., G.O.E.D., and the European Commission.

    In addition to raw material testing, as a GMP (Good Manufacturing Practices) certified company, we test three lots of fish oil from each potential bulk fish oil supplier. Heavy metals testing is done for items such as mercury, cadmium, and lead – verifying the Certificate of Analysis results of inbound raw materials against our own laboratory results. PCB testing is also performed to insure compliance with California Proposition 65, along with freshness/stability testing for shelf-life.
     

    PCB  Limits for EverLife Laboratories versus FDA and California Proposition 65:

    The Food and Drug Administration’s tolerance level for PCB’s in fish (2 ppm, listed in 21 CFR 109.30,) far exceeds EverLife Laboratories current specification for  PCB’s in fish oil (not more than 0.09 mg/kg of fish oil). The State of California has not established a “maximum allowable dose level” (MADL) for PCB’s related to reproductive toxicity. However, the California Office of Environmental Health Hazard Assessment (OEHHA) has established a “no significant risk level” (NSRL) related to carcinogenic activity of 0.09 mcg/ serving per day.
     

    Summary of PCB Limits

    FDA Limits for PCB’s in fish:

    2 ppm

    CA Prop 65 NSRL limit for PCB’s in fish oil:

    0.09 mcg/serving per day

    EverLife Labs fish oil limits for PCB’s:

    NMT 0.09 ppm (0.00000009)

     

    Stability and Freshness:

    Fats will quickly oxidize, so vitamin E is a common ingredient in fish oil supplements to prevent that. Vitamin E reduces oxidized fats. On the finished product we will test for vitamin E, if vitamin E is identified then the fish oil is still fresh, otherwise it would consume the vitamin E.
     

    Legend

    A

    U.S. Environmental Protection Agency. 0.1 mcg per kilogram of body weight per day. Example: 150lb (68 kg) person >> 68 kg x 0.1 mcg = 6.8 mcg per day consumed safely.

    B

    Specifications from the State of California Environmental Protection Agency, Of Environmental Health Hazard Assessment, Safe Drinking Water and Toxic Enforcement Act of 1986 also referred to as Proposition 65.

    mcg                micrograms

    NMT               Not more than

    ND                  Not detected

     

    Ingredients

    Antioxidants

    Docosahexaenoic Acid

    Eicosapentaenoic Acid

    Fatty Acids

    Fish Oil

    Omega 3

    Vitamin E

    Suggested Use:Take 1 softgel up to three times, preferably with a meal.

    Storage:

    Keep in a cool, dry place.

    Allergy Warnings:

    This product is contraindicated for individuals with hypersensitivity to any of its ingredients.

    Interactions:

    • Everyone has unique body chemistry. All patients should be aware of potential drug and supplement interaction. You are encouraged to consult with your primary health care professional before taking any supplement product.

    • If you are taking any blood thinning, blood pressure, or Non-steroidal anti-inflammatory (NSAIDs) medication please consult with your primary health care professional before taking this product.

    Pregnancy Warning:

    If you are pregnant, nursing, have any health condition, or are taking any medications please consult with your health care practitioner before using this product.

    Keep out of reach of children.

    Disclaimer:

    • The following scientific literature references, articles, and statements have not been evaluated by the Food and Drug Administration (FDA).
    • This product is not intended to treat, cure or prevent any disease.
    • Information about this product is intended for your general knowledge only and is not a substitute for professional medical advice or treatment.
    THANKS!
    1. Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012 Apr 9.

    2. Nodari S, Triggiani M, Campia U, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2011;57(7):870-879.

    3. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000.

    4. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2011 Aug 9.

    5. Liu T, Korantzopoulos P, Shehata M, Li G, Wang X, Kaul S. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart. 2011;97(13):1034-1040.

    6. Amminger GP, Schäfer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010 Feb;67(2):146.

    7. Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.

    8. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304(21):2363-2372. Epub 2010 Nov 15.

    9. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:49-52.

    10. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med. 2009;41:301-10.

    11. Hartweg J, Farmer AJ, Holman RR, Neil A. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol. 2009;20:30-8.

    12. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126:826-833.

    13. van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2008;88:706-713.

    14. Eslick GD, Howe PR, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2008 Sep 5.

    15. Emsley R, Niehaus DJ, Oosthuizen PP, et al. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: Results from a randomized, placebo-controlled trial. Psychiatry Res. 2008;161:284-291.

    16. Zhu FS, Liu S, Chen XM, et al. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol. 2008;14:6395-6400.

    17. Schubert R, Kitz R, Beermann C, et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol. 2008 Nov 11.

    18. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008 Dec 23;337:a2931.

    19. McKenney JM, Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm. 2007;64:595-605.

    20. Theobald HE, Goodall AH, Sattar N, et al. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr. 2007;137:973-978.

    21. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-1098.

    22. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056-1061.

    23. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2007 Dec 2.

    24. Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188:46-50.

    25. Schwellenbach LJ, Olson KL, McConnell KJ, et al. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low-dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr. 2006;25:480-485.

    26. Itomura M, Hamazaki K, Sawazaki S, et al. The effect of fish oil on physical aggression in schoolchildren - a randomized, double-blind, placebo-controlled trial. J Nutr Biochem. 2005;16:163-171.

    27. Richardson AJ, Montgomery P. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder. Pediatrics. 2005;115:1360-1366.

    28. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003;166:85-93.

    29. Cleland L, James M, Proudman S. The role of fish oils in the treatment of rheumatoid arthritis. Drugs. 2003;63:845-853.

    30. Zanarini MC, Frankenburg FR. Omega-3 Fatty Acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003;160:167-169.

    31. Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int.2003;23:27-36.

    32. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160:996-998.

    33. Khan F, Elherik K, Bolton-Smith C, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res. 2003;59:955-962.

    34. Grundt H, Nilsen DW, Mansoor MA, et al. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 2003;33:88-95.

    35. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003;38:1007-1021.

    36. Liu M, Wallmon A, Wallin R, et al. Effects of stable fish oil and simvastatin on plasma lipoproteins in patients with hyperlipidemia. Nutr Res. 2003;23:1027-1034.

    37. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med.2002;112:298-304.

    38. Schmitz PG, McCloud LK, Reikes ST, et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol.2002;13:184-190.

    39. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry.2002;159:477-479.

    40. Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens.2002;20:1493-1499.

    41. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59:913-919.

    42. Harel Z, Gascon G, Riggs S, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002;31:154-161.

    43. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:233-239.

    44. Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med. 2002;252:497-503.

    45. Blommers J, De Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: A randomized, double-blind, controlled trial. Am J Obstet Gynecol. 2002;187:1389-1394.

    46. Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001;139:189-196.

    47. Peet M, Brind J, Ramchand CN, et al. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res.2001;49:243-251.

    48. van Dam M, Stalenhoef AF, Wittekoek J, et al. Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia: a comparison with gemfibrozil. Clin Drug Invest.2001;21:175-181.

    49. Yam D, et. al. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases. Harefuah. 2001;140:1156-1158.

    50. Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry. 2001;158:2071-2074.

    51. Nenseter MS, Osterud B, Larsen T, et al. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis. 2000;10:323-330.

    52. Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23:1407-1415.

    53. Volker D, Fitzgerald P, Major G, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000;27:2343-2346.

    54. Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23:1407-1415.

    55. Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest.2000;30:58-65.

    56. Conquer JA, Martin JB, Tummon I, et al. Effect of DHA supplementation on DHA status and sperm motility in asthenozoospermic males. Lipids. 2000;35:149-154.

    57. Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr. 2000;83:629-635.

    58. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 2000;71:1085-1094.

    59. von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.

    60. Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension.1999;34:253-260.

    61. Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr.1999;129:207-213.

    62. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med.1995;332:977-982.

    63. Lungershausen YK, Abbey M, Nestel PJ, et al. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 1994;12:1041-1045.

    FAQ

    Frequently Asked Questions - Essential Fatty Acids

    • What is an omega-3?

      Omega-3s are essential fatty acids. A good example of this would be eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Both of these essential fatty acids are necessary for human health. The body can synthesize EPA and DHA; however, in very small quantities. Consequently, supplementation of these nutrients is necessary to ensure optimal health.

    • What are EPA and DHA?

      Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are long-chain fatty acids that have demonstrated health benefits. Consumption of omega-3 fatty acids has numerous benefits including heart health support, brain health support, and eye health support*

    • What are some dietary sources of omega-3 fatty acids?

      Rich dietary sources of omega-3 fatty acids are cold-water marine fish (i.e. sardines, anchovies, cod, tuna, salmon, halibut, mackerel and herring). Certain types of algae and shellfish also contain omega-3 fatty acids.

    • What are the benefits from regularly taking fish oil?

      Consumption of omega-3 fatty acids has numerous benefits including heart health support, brain health support, and eye health support*

    • Do your fish oil products contain high amounts of heavy metals?

      All of the fish oils in all of our fish-oil containing products are always tested for heavy metal contamination to provide safe products to our customers.

    • Is there any iodine in the fish oil in EPA & DHA softgels?

      Historically, the iodine content of our fish oil has been less than 1ppm. Typically the amount is extremely low.

    • What the difference is between molecularly distilled and steam distilled fish oils?

      Steam distillation is when steam is added to a mixture of two or more constituents. The two liquids are heated simultaneously and vaporize to an extent determined by their own volatility. This means that the boiling point of the mixture is lower than that of both constituents, and the percentage of each constituent in the vapor depends only on its vapor pressure at this temperature. This process is useful when a mixture contains one or more compounds that may be damaged by overheating.

      Molecular distillation distills substances at temperatures below their normal boiling points. The liquid is placed in a cylinder where a vacuum pump evacuates all of the air creating an environment where boiling can occur at lower than normal temperatures. This speeds the distillation process, increases the concentration of omega-3’s, and is as effective as steam distillation.

    • How much cholesterol is in Concentrated Omega-3 and Ultimate Omega Complex™?

      here is 1.2 mg cholesterol per softgel in Concentrated Omega-3 and 2 mg per softgel in Ultimate Omega Complex™.

    • What is the best way to take the fish oil product to avoid heartburn?

      Take it after or with a meal. It may help to take digestive enzymes for proper fat digestion.

    • Does the Concentrated Omega-3 contain any citric acid?

      Even though this product does contain orange oil there is NO citric acid.

    • What does the term “cold pressed” mean?

      Cold presses are run on essential fatty acid seed oils with either no externally supplied heating or with some sort of cooling capability. Our raw material supplier uses this non-polluting method that avoids gasoline-like hexane residues. None of the presses our supplier uses are hooked up to an external heat source. Whatever temperature is generated comes from the simple mechanical act of squeezing oil out of the seed. During this process, the oil temperature runs in the 48°C to 52°C (118°F to 125°F) range. The oils are exposed to this temperature for one minute.

      Our raw material supplier guarantees that all of their products adhere to the Codex standard for edible oil safety established by the World Health Organization.

    • Is there any MSG in the gelatin cap?

      No MSG is added to any of our products, however MSG may occur naturally in products containing glutamine.

    • Has the oil in the Borage Oil 1000 mg been tested for pyrrolizidine alkaloids?

      Yes, and it has a content of less than 4 mcg/kg, which is the limit. Pyrrolizidine alkaloids naturally occur in borage seeds and may be toxic to the liver in chronic high doses..

    • Do the Flaxseed Oil Softgels need to be refrigerated?

      No, this product does not need to be refrigerated because it is sealed in an airtight softgel to keep its contents from spoiling.

    • Are the flax and borage used in your essential fatty acid products hexane free?

      Yes, the flax and borage are cold pressed using no chemicals or high temperatures.

    • Does the flax and borage used in your essential fatty acid products contain pesticides?

      The borage and flax are free of herbicides and pesticides.

    • Is the Borage Oil wild or hybrid? Is it cold pressed?

      Yes, it is derived from wild crafted seed but is currently hybrid. It is cold-pressed.

    • Can vitamin K1 react badly with EPA/DHA, especially in terms of blood clotting?

      Vitamin K1 is a blood clotting agent. EPA and DHA have been shown to thin the blood, so they act in opposition. From the Linus Pauling Institute website: “The US FDA has ruled that intakes up to 3 g/day of long-chain omega-3 fatty acids (EPA and DHA) are Generally Recognized As Safe (GRAS) for inclusion in the diet, and available evidence suggests that intakes less than 3 g/ day are unlikely to result in clinically significant bleeding. Although the Institute of Medicine did not establish a tolerable upper level of intake (UL) for omega-3 fatty acids, caution was advised with the use of supplemental EPA and DHA, especially in those who are at increased risk of excessive bleeding.”

    • Does ALA convert only to DHA or both DHA and EPA?

      ALA converts to both EPA and DHA, although human conversion of ALA to these omega-3s are slow. Diets high in linoleic acid (omega-6) can reduce the conversion of ALA by up to 40%, as can saturated fat, trans fat and a deficiency of vitamins C, B3, B6, zinc and magnesium.

       From the Linus Pauling Institute website: “Excess of dietary LA compared to ALA results in greater net formation of AA (20:4n-6) than EPA (20:5n-3). The capacity for conversion of ALA to DHA is higher in women than men. Studies of ALA metabolism indicate that approximately 8% of dietary ALA is converted to EPA and 0-4% is converted to DHA in healthy young men. In healthy young women, approximately 21% of dietary ALA is converted to EPA and 9% is converted to DHA. The better conversion efficiency of young women compared to men appears to be related to the effects of estrogen. Although ALA is considered the essential omega-3 fatty acid because it cannot be synthesized by humans, evidence that human conversion of EPA and, particularly, DHA is relatively inefficient suggests that EPA and DHA may also be essential under some conditions.

    • Can adults take Kids DHA?

      Absolutely! Our product provides a great source of healthy omega-3s for kids, teens, adults and older adults.

    • What is Friend of the Sea?

      It is a non-profit, NGO (Non-Governmental Organization), involved in conservation of resources; focuses on auditing traditional, artisanal and small scale fisheries. Their mission is to conserve the marine habitat. As the only program certifying fish feed and fish oil - omega-3 supplements (in addition to fisheries), they manage the certification of products from sustainable fisheries and aquaculture. Their minimum criteria follows FAO (Food & Agriculture Organization of the United Nations) guidelines. To learn more about Friend of the Sea, visit their website: www.friendofthesea.org.

       

      SOURCES OF ESSENTIAL FATS

      FATTY ACID

      Omega

      DIETARY SOURCES

      LA (Linoleic Acid)

      6

      vegetable oils, nuts and seeds, borage oil, evening primrose oil

      GLA (Gamma Linoleic Acid)

      6

      borage oil, evening primrose oil, black currant seed oil, oatmeal

      ALA (Alpha Linolenic Acid)

      3

      flax seed oil, black currant seed oil, canola oil, soybeans, spirulina and green leafy vegetables, squash, walnuts, strawberries

      EPA (Eicosapentaenoic Acid)

      DHA (Docosahexaenoic Acid)

      3

      fish liver oils such as salmon, tuna, cod, mackerel and herring

    Congratulations, your item has been added to the shopping cart!

    Continue Shopping (or) Checkout
    visamastercarddiscover